An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India

NCT06257277 · clinicaltrials.gov ↗

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Contrast Enhancement in Magnetic Resonance Imaging

Interventions

DRUG: GBCAs

Sponsor

Bayer